Patents Assigned to NeuroPn Therapeutics
  • Piperidine urea derivatives as soluble epoxide hydrolase inhibitors
    Patent number: 12121515
    Abstract: Described herein are novel piperidine urea derived compounds and their pharmaceutical compositions for the treatment of conditions and diseases mediated by soluble epoxide hydrolase.
    Type: Grant
    Filed: August 7, 2023
    Date of Patent: October 22, 2024
    Assignee: NeuroPn Therapeutics, Inc.
    Inventors: Ish Khanna, Sivaram Pillarisetti
  • PIPERIDINE UREA DERIVATIVES AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20240294516
    Abstract: Described herein are novel piperidine urea derived compounds and their pharmaceutical compositions for the treatment of conditions and diseases mediated by soluble epoxide hydrolase.
    Type: Application
    Filed: April 23, 2024
    Publication date: September 5, 2024
    Applicant: NeuroPn Therapeutics, Inc.
    Inventors: Ish Khanna, Sivaram Pillarisetti
  • Piperidine urea derivatives as soluble epoxide hydrolase inhibitors
    Patent number: 11998538
    Abstract: Described herein are novel piperidine urea derived compounds and their pharmaceutical compositions for the treatment of conditions and diseases mediated by soluble epoxide hydrolase.
    Type: Grant
    Filed: April 14, 2022
    Date of Patent: June 4, 2024
    Assignee: NeuroPn Therapeutics
    Inventors: Ish Khanna, Sivaram Pillarisetti
  • PIPERIDINE UREA DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20240140930
    Abstract: Described herein are novel piperidine urea derived compounds and their pharmaceutical compositions for the treatment of neurodegenerative disorders and diseases mediated by soluble epoxide hydrolase.
    Type: Application
    Filed: September 29, 2023
    Publication date: May 2, 2024
    Applicant: NeuroPn Therapeutics Inc.
    Inventors: Ish Khanna, Sivaram Pillarisetti
  • PIPERIDINE UREA DERIVATIVES FOR CANCER THERAPY
    Publication number: 20240139172
    Abstract: Described herein are novel piperidine urea derived compounds and their pharmaceutical compositions for the treatment of cancer as a monotherapy or a combination therapy with chemotherapeutic agents and/or checkpoint inhibitors.
    Type: Application
    Filed: September 29, 2023
    Publication date: May 2, 2024
    Applicant: NeuroPn Therapeutics, Inc.
    Inventors: Ish Khanna, Sivaram Pillarisetti, Hans Marcus Malkmus, Kathrin Christin Kortschak
  • PIPERIDINE UREA DERIVATIVES AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20240075023
    Abstract: Described herein are novel piperidine urea derived compounds and their pharmaceutical compositions for the treatment of conditions and diseases mediated by soluble epoxide hydrolase.
    Type: Application
    Filed: August 7, 2023
    Publication date: March 7, 2024
    Applicant: NeuroPn Therapeutics, Inc.
    Inventors: Ish Khanna, Sivaram Pillarisetti
  • PIPERIDINE UREA DERIVATIVES AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20220354839
    Abstract: Described herein are novel piperidine urea derived compounds and their pharmaceutical compositions for the treatment of conditions and diseases mediated by soluble epoxide hydrolase.
    Type: Application
    Filed: April 14, 2022
    Publication date: November 10, 2022
    Applicant: NeuroPn Therapeutics, LLC
    Inventors: Ish Khanna, Sivaram Pillarisetti